Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maoqiang, Ma"'
Publikováno v:
Archives of Pharmacal Research. 44:427-438
Over the past 100 years, Salvia miltiorrhiza f. alba (Lamiaceae) (RSMA) roots have been used to cure thromboangiitis obliterans (TAO) in local clinics. This study aimed to confirm the anti-thrombotic efficacy of 12 phenolic acids obtained from RSMA a
Publikováno v:
Biomedicine & Pharmacotherapy. 156:113806
Stroke is a serious threat to human survival and health due to its high morbidity and mortality. The pathological mechanism of stroke is complex and involves various regulated cell death (RCD) modalities such as autophagy, apoptosis and necroptosis.
Publikováno v:
OncoTargets and therapy
Shuqian He, Guihui Zhang, He Dong, Maoqiang Ma, Qing Sun Department of Pathology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong, People’s Republic of China Abstract: Breast cancer is the second leading cause of cancer morta
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 66
Background The root of Salvia miltiorrhiza f. alba (RSMA) (Lamiaceae) is used for the treatment of patients with thromboangiitis obliterans (TAO) in traditional Chinese medicine. Previously, a mixture of phenolic acids extracted from RSMA has shown s
Autor:
Lan Ye, Yuhua Jiang, Huaying Hou, Jie Liu, Ying Xu, D.L. Sun, Maoqiang Ma, Xin Li, Xiaomei Li, Cuihong Wang
Publikováno v:
Japanese journal of clinical oncology. 45(5)
Objective The incidence of brain metastases greatly varies in patients with non-small-cell lung cancer, and molecular markers are considered to predict brain metastases. Therefore, this study sought to identify the predictive value and potential mech
Autor:
Dianshui Sun, Xin Li, Maoqiang Ma, Jie Liu, Ying Xu, Lan Ye, Huaying Hou, Cuihong Wang, Xiaomei Li, Yuhua Jiang
Publikováno v:
Japanese Journal of Clinical Oncology; May2015, Vol. 45 Issue 5, p464-473, 10p